Article
Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
Immunobiology - 1 Oct 2017
Posadas-Sánchez Rosalinda, López-Uribe Ángel René, Posadas-Romero Carlos, Pérez-Hernández Nonanzit, Rodríguez-Pérez José Manuel, Ocampo-Arcos Wendy Angélica, Fragoso José Manuel, Cardoso-Saldaña Guillermo, Vargas-Alarcón Gilberto
Abstract excerpt
The aim of this study was to evaluate the potential use of the I148M/PNPLA3 (rs738409) gene polymorphism as a susceptibility marker for premature coronary artery disease (pCAD) and/or cardiovascular risk factors in Mexican type 2 diabetes mellitus patients (T2DM). The polymorphism was genotyped by 5' exonuclease TaqMan assays in a group of 2572 subjects (1103 with pCAD and 1469 healthy controls) belonging to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
